Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Clinical Trial ID NCT01198535

PubWeight™ 10.06‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01198535

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015 2.02
2 Notch inhibitors for cancer treatment. Pharmacol Ther 2013 1.55
3 Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 2012 1.26
4 Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012 1.17
5 A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer 2012 1.05
6 Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastasis 2015 0.90
7 Advances in targeted and immunobased therapies for colorectal cancer in the genomic era. Onco Targets Ther 2016 0.81
8 Therapeutic approaches to target cancer stem cells. Cancers (Basel) 2011 0.80
9 Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 2016 0.78
Next 100